HISTOLOGICAL CHANGES OF THE PANCREAS IN DIABETES MELLITUS

Authors

  • Kamoldinova Rokhatoy Abdullayevna Lecturer, Andijan State Medical Institute (ASMI), Andijan, Uzbekistan Author

Keywords:

Keywords: Keywords: diabetes mellitus, pancreas, histology, pancreatic islets, β-cells, insulitis, islet amyloid, pancreatic fibrosis, type 1 diabetes, type 2 diabetes.

Abstract

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia resulting from impaired insulin secretion, insulin action, or both. The pancreas plays a central role in the pathogenesis of diabetes because the endocrine islets of Langerhans contain β-cells responsible for insulin production. Diabetes mellitus is associated with characteristic structural and cellular alterations affecting both the endocrine and exocrine compartments of the pancreas. In type 1 diabetes mellitus, the major histological findings include immune-mediated destruction of pancreatic β-cells, reduction of β-cell mass, and insulitis. In type 2 diabetes mellitus, pancreatic changes are characterized by progressive β-cell dysfunction and loss, islet amyloid deposition, fibrosis, vascular alterations, and changes in the exocrine tissue. This thesis reviews the principal histological changes of the pancreas in diabetes mellitus and discusses their relationship with disease pathogenesis, progression, and impaired pancreatic function.

References

1.Richardson, S. J., & Pugliese, A. (2022). 100 years of insulin: Pancreas pathology in type 1 diabetes: An evolving story. Journal of Endocrinology, 252(2), R41–R57. https://doi.org/10.1530/JOE-21-0358

2.Alexandre-Heymann, L., Mallone, R., Boitard, C., Scharfmann, R., & Larger, E. (2019). Structure and function of the exocrine pancreas in patients with type 1 diabetes. Reviews in Endocrine and Metabolic Disorders, 20(2), 129–149. https://doi.org/10.1007/s11154-019-09501-3

3.Bhowmick, D. C., Kudaibergenova, Z., Burnett, L., & Jeremic, A. M. (2022). Molecular mechanisms of amylin turnover, misfolding and toxicity in the pancreas. Molecules, 27(3), 1021. https://doi.org/10.3390/molecules27031021

4.Wright, J. J., Eskaros, A., Windon, A., Bottino, R., Jenkins, R., Bradley, A. M., Aramandla, R., Philips, S., Kang, H., Saunders, D. C., Brissova, M., & Powers, A. C. (2024). Exocrine pancreas in type 1 and type 2 diabetes: Different patterns of fibrosis, metaplasia, angiopathy, and adiposity. Diabetes, 73(7), 1140–1152. https://doi.org/10.2337/db23-0009

5.Leete, P. (2023). Type 1 diabetes in the pancreas: A histological perspective. Diabetic Medicine, 40(12), e15228. https://doi.org/10.1111/dme.15228

6.Eizirik, D. L., Szymczak, F., & Mallone, R. (2023). Why does the immune system destroy pancreatic β-cells but not α-cells in type 1 diabetes? Nature Reviews Endocrinology, 19, 425–434. https://doi.org/10.1038/s41574-023-00826-3

7.Khin, P. P., Lee, J. H., & Jun, H.-S. (2023). Pancreatic beta-cell dysfunction in type 2 diabetes. European Journal of Inflammation, 21. https://doi.org/10.1177/1721727X231154152

8.Wright, J. J., Eskaros, A., Windon, A., Bottino, R., Jenkins, R., Bradley, A. M., Aramandla, R., Philips, S., Kang, H., Saunders, D. C., Brissova, M., & Powers, A. C. (2024). Exocrine pancreas in type 1 and type 2 diabetes: Different patterns of fibrosis, metaplasia, angiopathy, and adiposity. Diabetes, 73(7), 1140–1152. https://doi.org/10.2337/db23-0009

Downloads

Published

2026-09-23